361 Capital »

Pacira Pharmaceuticals shares owned by 361 Capital

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $981k 19k 52.46
2020-03-31 $724k 22k 33.52
2019-06-30 $2.5M 57k 43.48
2018-12-31 $2.4M 57k 43.03
2018-09-30 $2.3M 47k 49.14

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Pacer Advisors
State Street Corporation
Renaissance Technologies
D. E. Shaw & Co
Dimensional Fund Advisors
Doma Perpetual Capital Management
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Invesco
Jpmorgan Chase & Co
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding Pacira Pharmaceuticals